Markets:

Overview

News

Currencies

International

Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

169.70 +2.79 (+1.67%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Europe's High: Irish GPs Against Pot, Switzerland-Spain Share Data On Cannabis Clubs & More ↗

October 20, 2023

Denmark: Medical Marijuana Pilot Program Experience 90% Growth In 12 Months

Via Benzinga

Topics Cannabis

Jazz Pharmaceuticals Explores Asset Sale Option, Possibly Cannabinoid Business: Report ↗

October 20, 2023

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is reportedly exploring strategic options comprising a potential sale.

Via Benzinga

2 Top Biotech Stocks to Buy in October ↗

October 03, 2023

Growth catalysts lie ahead for both of these players.

Via The Motley Fool

5 Genius Safe Stocks to Buy for the 4th Quarter of 2023 ↗

October 02, 2023

These highly profitable, time-tested companies can deliver for their shareholders in any economic climate.

Via The Motley Fool

4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip ↗

September 30, 2023

An 18% decline in the Nasdaq Composite from its all-time high means bargains still abound.

Via The Motley Fool

Topics Stocks

Where Jazz Pharmaceuticals Stands With Analysts ↗

September 29, 2023

Via Benzinga

Expert Ratings for Jazz Pharmaceuticals ↗

August 10, 2023

Via Benzinga

Where Jazz Pharmaceuticals Stands With Analysts ↗

July 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023 ↗

September 29, 2023

Via Benzinga

3 Cannabis Stocks That Should Be on Every Investor’s Radar This Fall ↗

September 27, 2023

The cannabis industry is a quiet place where huge upside potential is building up. As more regions legalize, cannabis stocks can soar.

Via InvestorPlace

Topics Cannabis

Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty

September 22, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal,...

Via FinancialNewsMedia

3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall ↗

September 20, 2023

Even with higher for longer interest rates, drug discovery moves on. That’s why it’s still a good time to look for biotech stocks to buy.

Via InvestorPlace

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023

Via Investor Brand Network

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023

EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END

Via FinancialNewsMedia

7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom ↗

September 19, 2023

Cannabis stocks re seeing renewed interest and these seven look like reasonable buys as rescheduling approaches for weed.

Via InvestorPlace

Topics Cannabis

Cannabis Industry Changes As Marijuana Rescheduling Looms ↗

September 15, 2023

As the Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the top...

Via Benzinga

Topics Cannabis

NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years ↗

September 12, 2023

NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035.

Via Benzinga

Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030 ↗

August 26, 2023

These two businesses may be sound, but generating returns in this industry has been tough, with no light at the end of the tunnel.

Via The Motley Fool

Topics Cannabis

Epidiolex Counterpart Debuts In Brazil's Cannabis Market As Its Maker Eyes TSX IPO ↗

August 23, 2023

Verdemed, a pharmaceutical company known for producing cannabis-derived products, has received five fresh approvals from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância...

Via Benzinga

Topics Cannabis

Jazz Pharmaceuticals' Neuroscience Pipeline Readouts In Focus: Analyst Lowers Price Target ↗

August 14, 2023

Cantor Fitzgerald analyst Charles C.

Via Benzinga

Cannabis Stock Gainers And Losers From August 11, 2023 ↗

August 11, 2023

Via Benzinga

Topics Cannabis

Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues? ↗

August 09, 2023

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results for the second quarter of 2023, along with its outlook for the remainder of the year.

Via Benzinga

3 Biotech Stocks You’ll Regret Not Buying Soon ↗

August 08, 2023

These top biotech stocks are must-buys with huge potential, leading the industry with high-rewards for investors.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 08, 2023

Via Benzinga

GOP Rep. Blasts FDA Over CBD Inaction During Historic Hearing: The Agency Wants More Money To Do Its Job ↗

July 28, 2023

For the first time, Congress officially addressed the impact of the U.S. Food and Drug Administration’s (FDA) inaction regarding the regulations of CBD products.

Via Benzinga

FDA, Get It Done! Says Senator In Bipartisan Push To Regulate CBD Products Prior To Committee Hearing ↗

July 21, 2023

A bipartisan group of U.S. lawmakers reintroduceda measure on Wednesdaythat aims to secure theFood and Drug ...

Via Benzinga

Divided GOP Helps This State Dodge Bullet From The Pot Lobby, Says Anti-Marijuana Group ↗

July 10, 2023

Is the battle for medical marijuana legalization in North Carolina over for this year? Some groups say yes, some say know, here is what happened.

Via Benzinga

4 Unequaled Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip ↗

July 08, 2023

Bargains are hiding in plain sight with the Nasdaq Composite still well below its November 2021 record-closing high.

Via The Motley Fool

Jazz Pharmaceuticals Sues FDA Over Approval Of Rival Product, Calls It 'Unlawful' ↗

June 23, 2023

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has filed suit against the FDA for approving Avadel Pharmaceuticals Plc's (NASDAQ: AVDL) Lumryz (sodium oxybate extended-release) for cataplexy or excessive day

Via Benzinga

10 Cannabis Stocks That Could Go Sky High In 2023 ↗

June 18, 2023

With cannabis legalization gaining momentum, investing in cannabis presents a lucrative opportunity. Investors may want to explore cannabis stocks to enhance their portfolios. Here are the top 10...

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.